Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome

about

XPD-The Lynchpin of NER: Molecule, Gene, Polymorphisms, and Role in Colorectal Carcinogenesis.SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand.

P2860

Q52332662-6EDDB428-C261-4E9F-9191-4DCFD8434242 Q55497899-4DA95297-0B86-4D1D-9374-B89443272287

P2860

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome

Item

http://www.wikidata.org/entity/Q36656187

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome

@ast

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome

@en

type

Item

label

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome

@ast

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome

@en

prefLabel

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome

@ast

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome

@en

P1476

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome

@en

P2093

Hui-Jen Chang

http://www.w3.org/2001/XMLSchema#string

Jaw-Yuan Wang

http://www.w3.org/2001/XMLSchema#string

Meng-Lin Huang

http://www.w3.org/2001/XMLSchema#string

Ming-Yii Huang

http://www.w3.org/2001/XMLSchema#string

Shiu-Ru Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer

ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study

Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy.

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

Current status of clinical studies for colorectal cancer in Taiwan.

The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer.

A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment.

Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years.

Interaction of molecular markers and physical activity on mortality in patients with colon cancer.

P304

4121-4134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS14024121

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235689809

http://www.w3.org/2001/XMLSchema#string

P698

23429196

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3588089

http://www.w3.org/2001/XMLSchema#string

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome

about

P2860

P2860

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932